BR112015027026A2 - composição para uso na redução da formação de crosta e na promoção da cicatrização - Google Patents
composição para uso na redução da formação de crosta e na promoção da cicatrizaçãoInfo
- Publication number
- BR112015027026A2 BR112015027026A2 BR112015027026A BR112015027026A BR112015027026A2 BR 112015027026 A2 BR112015027026 A2 BR 112015027026A2 BR 112015027026 A BR112015027026 A BR 112015027026A BR 112015027026 A BR112015027026 A BR 112015027026A BR 112015027026 A2 BR112015027026 A2 BR 112015027026A2
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- promoting healing
- crust formation
- reducing
- reducing crust
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A61K31/231—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms having one or two double bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1350518 | 2013-04-26 | ||
PCT/SE2014/050487 WO2014175814A1 (en) | 2013-04-26 | 2014-04-23 | Composition for use in reducing scab formation and promoting healing |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112015027026A2 true BR112015027026A2 (pt) | 2017-07-25 |
BR112015027026A8 BR112015027026A8 (pt) | 2018-01-30 |
Family
ID=51792217
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112015027026A BR112015027026A8 (pt) | 2013-04-26 | 2014-04-23 | composição para uso na redução da formação de casca e na promoção da cicatrização |
Country Status (10)
Country | Link |
---|---|
US (1) | US20160081968A1 (pt) |
EP (1) | EP2988731B1 (pt) |
CN (1) | CN105338963A (pt) |
AU (1) | AU2014257984B2 (pt) |
BR (1) | BR112015027026A8 (pt) |
CA (1) | CA2910114A1 (pt) |
ES (1) | ES2860578T3 (pt) |
HK (1) | HK1224175A1 (pt) |
PL (1) | PL2988731T3 (pt) |
WO (1) | WO2014175814A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
CN110087631A (zh) * | 2016-12-16 | 2019-08-02 | 北欧油脂集团(上市公司) | 矿脂替代品制剂 |
JP7364556B2 (ja) * | 2017-05-23 | 2023-10-18 | ファーミバ アーベー | 体腔に活性物質を送達するための泡形成性組成物 |
CN108697629B (zh) * | 2017-09-05 | 2021-10-15 | 拉芳家化股份有限公司 | 一种天然替代的植物精油防腐剂及在化妆品中的应用 |
US11166925B2 (en) | 2018-08-23 | 2021-11-09 | Elorac, Inc. | Method for alleviating keratoconjunctivitis sicca |
CN112384208A (zh) * | 2018-08-23 | 2021-02-19 | 埃洛拉克有限公司 | 用于缓解干燥性角膜结膜炎的方法和组合物 |
CA3175700A1 (en) * | 2021-06-11 | 2022-12-11 | Ankh Life Sciences Limited | Lipid crystalline compositions with enhanced stability for topical delivery of active agent combinations |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL297511A (pt) * | 1956-12-20 | |||
DK116528A (pt) * | 1966-09-30 | |||
JPS58500285A (ja) * | 1981-03-17 | 1983-02-24 | ビオグラム・アクチエボラーグ | 殺菌性組成物 |
US5143934A (en) * | 1990-11-21 | 1992-09-01 | A/S Dumex (Dumex Ltd.) | Method and composition for controlled delivery of biologically active agents |
AU685262B2 (en) * | 1994-03-30 | 1998-01-15 | Gs Development Ab | Use of fatty acid esters as bioadhesive substances |
US8535709B2 (en) * | 2004-12-13 | 2013-09-17 | Southeastern Medical Technologies, Llc | Agents for controlling biological fluids and methods of use thereof |
-
2014
- 2014-04-23 BR BR112015027026A patent/BR112015027026A8/pt active Search and Examination
- 2014-04-23 WO PCT/SE2014/050487 patent/WO2014175814A1/en active Application Filing
- 2014-04-23 CA CA2910114A patent/CA2910114A1/en not_active Abandoned
- 2014-04-23 CN CN201480036924.5A patent/CN105338963A/zh active Pending
- 2014-04-23 EP EP14788755.8A patent/EP2988731B1/en active Active
- 2014-04-23 AU AU2014257984A patent/AU2014257984B2/en active Active
- 2014-04-23 ES ES14788755T patent/ES2860578T3/es active Active
- 2014-04-23 PL PL14788755T patent/PL2988731T3/pl unknown
- 2014-04-23 US US14/786,930 patent/US20160081968A1/en not_active Abandoned
-
2016
- 2016-08-12 HK HK16109680.8A patent/HK1224175A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ES2860578T3 (es) | 2021-10-05 |
CN105338963A (zh) | 2016-02-17 |
EP2988731A4 (en) | 2016-05-18 |
CA2910114A1 (en) | 2014-10-30 |
AU2014257984B2 (en) | 2019-07-11 |
BR112015027026A8 (pt) | 2018-01-30 |
EP2988731B1 (en) | 2021-02-17 |
PL2988731T3 (pl) | 2021-08-02 |
EP2988731A1 (en) | 2016-03-02 |
HK1224175A1 (zh) | 2017-08-18 |
US20160081968A1 (en) | 2016-03-24 |
WO2014175814A1 (en) | 2014-10-30 |
AU2014257984A1 (en) | 2015-11-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223975A1 (zh) | 含納米氣泡的組合物及其用途 | |
CL2015000128A1 (es) | Composición para controlar enfermedades en plantas y el uso de la misma | |
HK1216004A1 (zh) | 固溶體組合物及其在慢性炎症中的用途 | |
CO6831975A2 (es) | Inmunoconjugados, composiciones para prepararlos, métodos para prepararlos y uso | |
BR112015027026A2 (pt) | composição para uso na redução da formação de crosta e na promoção da cicatrização | |
GB201317286D0 (en) | Composition and Use | |
EP3328414A4 (en) | COMPOSITION FOR USE IN PROMOTING WOUND HEALING | |
CL2015002146A1 (es) | Composiciones y procedimientos para tratar heridas superficiales | |
EP3075379A4 (en) | Agent for promoting in vivo absorption of hydroxytyrosol and derivatives thereof and use of same | |
FI2956471T3 (fi) | Il-1-beetan estäjän koostumus ja sen käyttö | |
CL2016000998A1 (es) | Composición herbaria, procedimiento para su preparación y uso de la misma | |
BR112015021722A2 (pt) | composição para uso no tratamento de síndrome do ovário policístico | |
SMT201700004B (it) | Uso di estratti di salvia haenkei in composizioni per antisenescenza | |
HK1223906A1 (zh) | 用於建築材料的鳥糞石- 及鉀石膏組合物 | |
CL2014000792A1 (es) | Composicion para uso en la promocion de absorcion de magnesio y/o retencion de magnesio | |
IL245015A0 (en) | Medicinal composition containing icotinib for topical treatment of the skin and its use | |
GB201301979D0 (en) | New composition and use thereof | |
BR112015023621A8 (pt) | derivados de meropenem e suas utilizações | |
BR112015006960A2 (pt) | uso de uma combinação, composição e método para preparar um produto de espuma | |
FR2994385B1 (fr) | Composition cosmetique biphasique conditionnee en flacon-pompe | |
CL2015003706A1 (es) | Composiciones vacunales bivalentes y su uso para la terapia de tumores | |
FR3007291B1 (fr) | Composition cicatrisante et utlisation | |
GB2516064B (en) | Improvements in and relating to radar | |
CL2015002599A1 (es) | Composiciones y métodos para la orientación de n-acetilglucosamina transferasa unida al oxigeno y promover sanamiento de heridas | |
BR112014032456A2 (pt) | métodos in vitro, composição farmacêutica, kit para realização do método e método para melhorar o efeito de tratamento |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B06I | Publication of requirement cancelled [chapter 6.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 6.21 NA RPI NO 2555 DE 24/12/2019 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 6A ANUIDADE. |
|
B08H | Application fees: decision cancelled [chapter 8.8 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.6 NA RPI NO 2563 DE 18/02/2020 POR TER SIDO INDEVIDA. EM VIRTUDE DO 1.3.4 QUE ANULOU O 1.3. |
|
B350 | Update of information on the portal [chapter 15.35 patent gazette] |